Background Image
Menu

News: 2020

Catapult Ventures announces investment in Panthera Biopartners

29 September 2020

Catapult Ventures announces investment in Panthera Biopartners

29 September 2020 - Manchester, UK. Panthera Biopartners (Panthera) has completed a Series A funding round from Gresham House Ventures and the GM&C Life Sciences Fund, managed by Catapult Ventures. Panthera is an independent site management organisation (SMO) that finds...

Covid-19 Pandemic Spurs Adoption and Investment in Digital Health Technologies

7 September 2020

Covid-19 Pandemic Spurs Adoption and Investment in Digital Health Technologies

Gareth King, Life Science Partner with Catapult Ventures looks at some of the most exciting areas and companies leading the transformation in digital health spurred by the Covid-19 pandemic. See the full blog in Insider here

Clin-e-Cal launches Crowdcube campaign

2 September 2020

Clin-e-Cal launches Crowdcube campaign

Clin-e-cal uses its patented Sound Response technology to develop apps to provide real-time feedback to inhaler users & facilitate remote disease management. With thousands of downloads, they're on a mission to help the world’s 500m asthma & COPD sufferers. Raising...

Cytox signs licence agreement with Cardiff University for polygenic risk score technology key to development of lead product genoSCORE(TM)

2 September 2020

Cytox signs licence agreement with Cardiff University for polygenic risk score technology key to development of lead product genoSCORE(TM)

2nd September 2020: Oxford & Manchester, UK. Cytox Ltd, which provides non-invasive, risk assessment and patient stratification tools for Alzheimer's disease and dementia, has signed a license agreement with Cardiff University to access the University’s Intellectual...

Catapult Ventures announces investment in digital health start-up MyHelp

28 July 2020

Catapult Ventures announces investment in digital health start-up MyHelp

22nd July 2020 - Manchester, UK. MyHelp, a Manchester based start-up building a digital solution for mental health service providers and patients has received investment from Catapult Ventures’ GM&C Life Sciences Fund. The company is founded by Kirren Kaur and Indi...

Catapult Ventures invests in agricultural synthetic biology start-up CroBio

20 July 2020

Catapult Ventures invests in agricultural synthetic biology start-up CroBio

15th July 2020, Alderley Park: Catapult Ventures’ GM&C Life Sciences Fund is pleased to announce an investment in CroBio, an agricultural biotechnology start-up specialising in synthetic biology based at Alderley Park, Cheshire. CroBio aims to engineer a novel...

Catapult announces the sale of Oracle Care & Education

14 July 2020

Catapult announces the sale of Oracle Care & Education

Catapult Ventures is delighted to announce the sale of Oracle Care & Education in a deal that generated a cash return of 3.4x for the Catapult Growth Fund. Nick Wright, Catapult CEO said: “The fact that we were able to complete this transaction whilst in the middle of...

YourMedPack announces growth funding from Catapult Ventures for smart medication packs

9 July 2020

YourMedPack announces growth funding from Catapult Ventures for smart medication packs

8th July 2020, Manchester, UK: YourMedPack Ltd, a leading provider of smart medication packs to support patients at home and in care, today announces £600,000 funding from the Greater Manchester & Cheshire Life Sciences Fund, managed by Catapult Ventures, and existing...

Gendius awarded a share of £200,000 through Health Innovation Manchester Momentum Fund

30 June 2020

Gendius awarded a share of £200,000 through Health Innovation Manchester Momentum Fund

Gendius is one of four digital healthcare projects supporting the COVID-19 response awarded a share of £200,000 through Health Innovation Manchester Momentum Fund. Artificial Intelligence to support patients to manage their diabetes, a Clinical Decision Platform to help...

Major boost in global fight against antimicrobial resistance as AMR Centre receives share of Strength in Places Fund award

26 June 2020

Major boost in global fight against antimicrobial resistance as AMR Centre receives share of Strength in Places Fund award

The AMR Centre has combined forces to attract much needed investment to combat the global threat of antimicrobial resistance (AMR) resulting in a successful bid for a £114 million project supported by UK Research and Innovation (UKRI). The funding was secured by a North...